Business Value: Xtant Medical (XTNT)

Xtant Medical Holdings (XTNT) specializes in the development of implants and bone grafts for spinal surgery. The historical price action of the Enterprise Value, which stands at 55.10, reflects the market valuation of the business. The company aims to expand its presence in US clinics by developing distribution channels, while the modernization of CNC equipment allows for the optimization of production output at fully utilized plants.

Enterprise Value (EV) reflects the actual acquisition price of a business by summing market capitalization and debt, minus liquid assets. This metric allows for an assessment of investment efficiency in the development of biomaterials for spinal surgery in collaboration with clinics. By analyzing the historical trend of enterprise value, an investor can identify whether the company is overvalued or undervalued. This price action reflects the ability of Xtant Medical (XTNT) to fund innovation, which determines the long-term sustainability of the business.